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Numerous studies have identified reinforcement learn-
ing (RL) deficits in schizophrenia. Most have focused on 
chronic patients with longstanding antipsychotic treat-
ment, however, and studies of RL in early-illness patients 
have produced mixed results, particularly regarding grad-
ual/procedural learning. No study has directly contrasted 
both rapid and gradual RL in first-episode psychosis (FEP) 
samples. We examined probabilistic RL in 34 FEP patients 
and 36 controls, using Go/NoGo (GNG) and Gain vs Loss-
Avoidance (GLA) paradigms. Our results were mixed, with 
FEP patients exhibiting greater impairment in the ability to 
use positive, as opposed to negative, feedback to drive rapid 
RL on the GLA, but not the GNG. By contrast, patients and 
controls showed similar improvement across the acquisition. 
Finally, we found no significant between-group differences 
in the postacquisition expression of value-based preference 
in both tasks. Negative symptoms were modestly associ-
ated with RL measures, while the overall bias to engage in 
Go-responding correlated significantly with psychosis sever-
ity in FEP patients, consistent with striatal hyperdopami-
nergia. Taken together, FEP patients demonstrated more 
circumscribed RL impairments than previous studies have 
documented in chronic samples, possibly reflecting differ-
ential symptom profiles between first-episode and chronic 
samples. Our finding of relatively preserved gradual/proce-
dural RL, in briefly medicated FEP patients, might suggest 
spared or restored basal ganglia function. Our findings of 
preserved abilities to use representations of expected value 
to guide decision making, and our mixed results regarding 
rapid RL, may reflect a lesser degree of prefrontal corti-
cal functional impairment in FEP than in chronic samples. 
Further longitudinal research, in larger samples, is required.
Key words:  decision making/psychosis/prefrontal 
cortex/basal ganglia/dopamine/prediction error
Introduction
Recent years have seen increased interest in mechanisms of 
reinforcement learning (RL) in schizophrenia (SZ),1–3 based 
on evidence that dopamine pathways4,5 and frontostriatal 
circuits6 are both critically involved in RL and implicated 
in the pathophysiology of SZ.7–9 Complicating the picture, 
however, findings point to a variety of RL deficits in SZ,1–3 
with different aspects of RL likely drawing on different 
neural substrates and relating to different symptom dimen-
sions. The capacity for rapid/explicit RL, eg, relies heavily 
on fronto-hippocampal circuits, perhaps centered on orbi-
tofrontal cortex,10–12 whereas gradual/procedural learning, 
and the expression of acquired habits, depends on the ability 
to learn from repeated response sequences, or from repeated 
receipt of probabilistic feedback, and is thought to rely, pre-
dominantly, on the basal ganglia (BG).13 Furthermore, both 
rapid/explicit and gradual/procedural forms of RL can be 
driven by either rewards or punishments or both.6,14
Behavioral studies have revealed impairment in rapid 
trial-to-trial learning of reinforcement contingencies in 
SZ,1 especially in patients with more severe negative symp-
toms.15,16 Findings regarding gradual/procedural learning 
in SZ, using paradigms such as serial reaction time (SRT) 
tasks17,18 and probabilistic discrimination learning,19–22 
are more mixed. Several studies indicate that SZ patients 
may demonstrate compromised reward-driven learning, 
in the presence of relatively intact punishment-driven 
learning.15,16,23,24 Functional neuroimaging studies have 
confirmed a role for frontostriatal dysfunction in the RL 
deficits observed in SZ, especially regarding reward antici-
pation25–28 and reward prediction error (RPE) signaling.29–32
Of note, the majority of previous RL studies in SZ 
have focused on patients with chronic illness, where it 
is difficult to address potentially adverse consequences 
of prolonged treatment exposure and illness chronicity. 
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However, at least 10 studies have examined RL in first-
episode psychosis (FEP). Four studies probed rapid 
RL using reversal learning or related paradigms, and 
all found evidence of impairment in FEP patients,33–36 
suggesting deficits in the use of feedback to make rapid 
behavioral adjustments. Five studies examined gradual/
procedural RL using SRT or related tasks, with 3 demon-
strating significantly poorer learning in patients, relative 
to controls.37–39 Two neuroimaging studies reported a lack 
of between-group differences in procedural RL,29,40 but 
the goal of these studies was likely to determine whether 
group differences in neural responses would be observed 
in the presence of similar behavioral performance. Finally, 
a study using a causal learning paradigm to examine PE 
signaling41 also found that patients exhibited intact per-
formance but abnormal neural correlates of learning.
To date, no study has investigated RL with the goal of 
distinguishing between rapid/explicit and gradual/proce-
dural RL, and between reward- and punishment-driven 
RL. Furthermore, no FEP study has investigated RL 
with the goal of distinguishing between the acquisition 
of reward contingencies and the successful use of value 
representations, established over the course of learning, 
in decision making. In the current study, we sought to 
do this in a representative cohort of Chinese patients 
with clinically stabilized FEP, using 2 probabilistic RL 
paradigms: the Go/NoGo (GNG) task and the Gain vs 
Loss-Avoidance (GLA) task. These tasks confer several 
advantages over RL paradigms used to date. First, in 
each task, both rapid and gradual RL can be examined. 
Second, both tasks allow one to assess learning from 
both positive and negative feedback. Moreover, these 
tasks allowed us to investigate 2 additional aspects of RL 
not previously assessed in FEP. The GNG task enables 
us to quantify the general tendency of participants to 
make (vs withhold) responses, irrespective of reward con-
tingencies.16 This behavioral index (termed “Go-response 
bias”) has been hypothesized to result from high tonic 
dopamine levels in the striatum.42 The GLA task allows 
one to dissociate contributions that expected value (EV) 
representations make to RL, from those made by RPE 
signaling.43 In this task, selection of the correct item from 
some stimulus-pairs (gains vs neutral outcomes) leads 
to reward; in other pairs (losses vs neutral outcomes), 
correct-response selection results in loss-avoidance. Both 
types of correct selections should lead to positive RPEs, 
but some selections are associated with positive EV, oth-
ers with negative EV. Examining participants’ preferences 
between stimuli with different EVs, but identical frequen-
cies of positive RPEs, in a Test/transfer phase following 
Acquisition, offers a critical evaluation of impairment in 
EV representation.
Previous studies have shown evidence of impairment 
on these tasks in chronic SZ.16,43 In a study using the 
GNG task,16 chronic patients showed attenuations in both 
rapid punishment-driven RL and gradual reward-driven 
learning, despite higher overall levels of Go-responding 
(a Go-response bias). Furthermore, measures of all 3 of 
these constructs tracked with negative symptom sever-
ity. Our prior study using the GLA task43 revealed that 
chronic patients with the highest negative symptoms 
showed no preference for frequently rewarded stimuli 
(positive EV) over stimuli frequently associated with loss-
avoidance (negative EV). These findings, and others from 
our group,15,23,44 have documented the impact of negative 
symptom severity on aspects of RL and decision making, 
suggesting that this symptomatic feature of the illness, 
rather than the diagnosis per se, may be primarily impli-
cated in the extent of RL deficits.
Because many of our previous results have been related 
to negative symptom severity, it is difficult to make strong 
predictions about the overall performance of a FEP sam-
ple, where we would expect prominent positive symptoms, 
but less-severe negative symptoms than those observed 
in prior studies of chronic patients at the Maryland 
Psychiatric Research Center (MPRC). Thus, we predicted 
that FEP patients would demonstrate relatively mild defi-
cits, when compared with controls, in overall RL (learn-
ing across the Acquisition phase). However, we expected 
that patients with the most severe negative symptoms 
would show deficits in rapid RL, and in EV representa-
tion. Based on computational models, as well as evidence 
indicating that acute psychosis is accompanied by stria-
tal hyperdopaminergia,7 we predicted that a Go-response 
bias on the GNG task would be characteristic of FEP 
patients with the most severe positive symptoms.
Methods
Participants
Thirty-four patients in their first psychotic episode, aged 
15–40 years, were recruited from the outpatient unit of 
a specialized early intervention service for FEP in Hong 
Kong (HK). Diagnosis was ascertained at intake using 
the Chinese-bilingual Structured Clinical Interview for 
DSM-IV (CB-SCID-I/P)45 and revisited after clinical sta-
bilization (28 received a DSM-IV46 diagnosis of SZ and 6 
received a diagnosis of schizophreniform disorder). Study 
assessments were administered to patients 3–7  months 
following antipsychotic initiation (mean: 161.9 d; SD: 
34.2 d), at which point all patients had been on stable 
antipsychotic regimens for at least 4 weeks (most with 
second-generation antipsychotic (SGA) monotherapy; 
see table 1 and supplementary table S1 for details).
Thirty-six healthy controls were recruited from the 
community via advertisements and word-of-mouth 
among recruited participants. Patients and controls were 
matched for age, gender, and educational level. Controls 
were screened to confirm that they had no psychiat-
ric diagnosis (by CB-SCID-I/P), family history of psy-
chotic disorder, and were not taking any psychotropic 
medications.
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The study was approved by the local institutional 
review boards, and all participants provided written 
informed consent. Any individual showing evidence of 
substance abuse (according to the Alcohol Use Scale and 
the Drug Use Scale47), intellectual disability, or neurolog-
ical disease was excluded from participation.
Clinical and Cognitive Assessments
Positive and disorganization symptoms were assessed 
using the Positive and Negative Syndrome Scale 
(PANSS).48 Based on our previous work, negative 
symptom severity was quantified using the Scale for 
the Assessment of Negative Symptoms (SANS).49 As 
evidence suggested that the amotivation subdomain 
of negative symptoms may be specifically linked to RL 
impairment,3 we computed an amotivation score by sum-
ming all items from the Avolition/Apathy and Anhedonia/
Asociality subscales of the SANS, excluding global items. 
Depression was evaluated using the Calgary Depression 
Scale (CDS).50 Cognitive assessments, comprising letter-
number span (working memory measure),51 visual pat-
tern test,52 monotone counting,53 and logical memory and 
visual reproduction subtests from the Wechsler Memory 
Scale–Revised (WMS–R)54 were administered to all par-
ticipants. The 3-subtest short-form55 of the WAIS-III was 
used to generate IQ estimates. Controls had higher IQs 
and performed better than patients on the letter-number 
Table 1. Demographics, Cognitive Functions, Clinical and Treatment Characteristics of Patients and Controls
GNG Task GLA Task
Patients Controls Patients Controls
Variablesa (n = 31) (n = 33) P (n = 31) (n = 33) P
Demographics
 Age 24.8 (7.4) 23.7 (7.5) .54 24.1 (7.5) 23.7 (7.5) .83
 Male gender, n (%)b 13 (41.9) 16 (48.5) .68 12 (38.7) 14 (42.4) .76
 Nicotine-dependent, n (%) 4 (12.9) 3 (9.1) .70 4 (12.9) 3 (9.1) .70
 Years of education 12.5 (2.7) 12.7 (2.7) .75 12.2 (2.6) 12.8 (2.6) .43
Cognitive function
 Letter number span 12.9 (3.7) 15.6 (4.4) <.01 12.9 (3.7) 16.0 (3.0) <.01
 Visual pattern 19.7 (3.9) 24.7 (4.7) <.01 20.4 (16.3) 24.9 (4.7) <.01
 Logical memory 10.9 (4.4) 12.6 (4.4) .12 10.9 (4.2) 12.6 (4.4) .11
 Visual reproduction 20.9 (1.2) 21.2 (2.0) .52 21.0 (1.2) 21.1 (2.1) .69
 Monotone counting 11.4 (1.8) 12.0 (0.2) .08 11.4 (1.8) 12.0 (0.2) .08
 Intelligence estimate 96.8 (12.1) 114.3 (11.9) <.001 96.4 (11.2) 114.4 (11.3) <.001
Clinical characteristics
 Age at onset 23.7 (7.2) N/A 22.9 (7.3) N/A
 DUP in days (median)c 123 N/A 123 N/A
 Diagnoses 25 SZ, 6 SP N/A 25 SZ, 6 SP N/A
 PANSS total score 41.6 (8.7) N/A 41.9 (8.5) N/A
 SANS total score 14.2 (13.1) N/A 11.2 (12.4) N/A
 CDS total score 1.4 (2.6) N/A 1.6 (2.8) N/A
Treatment characteristics
 Haloperidol equivalentsd 3.7 (2.5) N/A 3.7 (2.6) N/A
 Antipsychotic regimen, n (%)
  FGA monotherapy 2 (6.5)e N/A 2 (6.5)e N/A
  SGA monotherapy 25 (80.6)f N/A 25 (80.6)g N/A
  Combined antipsychotics 4 (12.9)h N/A 4 (12.9)h N/A
Note: CDS, Calgary Depression Scale; DUP, duration of untreated psychosis; FGA, first-generation antipsychotic; GNG, Go/NoGo; 
GLA, Gain vs Loss-Avoidance; PANSS, Positive and Negative Syndrome Scale; SANS, Scale for the Assessment of Negative Symptoms; 
SGA, second-generation antipsychotic; SP, schizophreniform disorder; SZ, schizophrenia.
aVariables were presented in mean and SD except gender, antipsychotic regimen, and DUP. Gender and antipsychotic regimen were 
presented in number and percentage, while DUP was presented in median due to its skewed distribution.
bIndependent-samples t-tests were performed for patient-control comparison in demographics and cognitive functions except in the case 
of assessing between-group differences in gender breakdown and smoker/nonsmoker breakdown. These differences were examined using 
Chi-square tests.
cDUP was measured by the Interview for Retrospective Assessment of the Onset of Schizophrenia (IRAOS).64
dHaloperidol equivalents were computed according to the method of Andreasen et al (2010).56
e1 on haloperidol and 1 on flupenthixol depot injection.
f14 on risperidone, 4 on amisulpride, 4 on olanzapine, 2 on quetiapine, and 1 on aripiprazole.
g12 on risperidone, 5 on quetiapine, 4 on amisulpride, 3 on olanzapine, and 1 on aripiprazole.
h2 on risperidone and quetiapine, and another 2 on risperidone and aripiprazole.
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span and visual pattern test (table  1). No group differ-
ences were observed on other cognitive tests.
RL Tasks
Two computerized probabilistic RL paradigms were admin-
istered to each participant. Details of these RL tasks have 
been described in previous reports,16,43 and the same task 
parameters were used in the current study, in the case of 
each paradigm (see supplementary materials). Participants 
were compensated HK$100 (US$13) for completion of the 
study and could earn bonuses of up to HK$200 (US$26), 
based on RL task performance. The range of compen-
sation for participation was roughly on par with that of 
previous studies conducted at the MPRC,16,43 representing 
about 2% of the median monthly income in HK.
Outcome Measures and Statistical Analysis
In each of the 2 experiments, data from 3 patients and 
3 controls who did not appear to understand or engage 
with the task according to the tester, and responded with 
random button-pressing, were removed from analysis.
We operationalized 4 constructs, in the context of our 
RL tasks: (1) an overall bias to make Go-responses on the 
GNG task, (2) rapid/explicit RL, (3) overall RL (thought 
to involve a combination of explicit and procedural 
mechanisms), and (4) the expression of postacquisition 
value-based preference in the absence of feedback (see 
table 2). In the context of the GLA task, we also assessed 
the relative benefit of positive EV vs negative EV during 
Acquisition by computing gain-pair vs loss-avoidance-
pair difference scores for each individual. Computation 
of RL measures and statistical analyses conducted in the 
Table 2. Hypotheses, Reinforcement Learning Constructs and Corresponding Dependent Variables Based on the GNG and the GLA 
Tasks Studied in First-Episode Psychosis Patients
Reinforcement Learning Constructs and Hypotheses Results from the Current FEP sample
Construct 1 Go-Response Bias16
 Hypothesis Will correlate with positive symptom severity -  No Go-response bias was observed in the overall 
patient sample.
-  Overall Go-rate correlated with PANSS positive 
symptom score.
 Measure Overall Go-rate (GNG)
Construct 2 Rapid Reinforcement Learning15,16
 Hypothesis  Will be disrupted in FEP patients -  Patients had lower win-stay rate on the GLA task 
than controls.
-  GLA win-stay rate correlated with SANS total 
score.
-  No rapid RL impairment was observed on the 
GNG task.
Will correlate with negative symptom severity
 Measures Lose-shift rate (GNG & GLA)
Win-stay rate (GNG & GLA)
Construct 3 Overall Reinforcement Learning15,16,43
 Hypothesis Will be mildly impaired in FEP patients -  Patients performed worse than controls on 
the positive stimuli in the GNG task and both 
positive (gain) and negative (loss- 
avoidance) stimuli in the GLA task.
-  Patients showed longer response latencies to 
positive stimuli than controls in the GNG task, but 
no deficit in RT acceleration to positive stimuli.
-  Overall RL measures did not correlate with 
negative symptoms
Will correlate with negative symptom severity
 Measure s Acquisition RT acceleration to positive stimuli (GNG)
Learning across Acquisition blocks (GNG & GLA)
Construct 4 Value-guided Choice16,43
 Hypothesis Will be mildly impaired in FEP patients -  Comparable performance between patients and 
controls on value-guided decision-making in both 
GNG and GLA tasks.
-  Patients’ [FP − NNeu] contrast values correlated 
with SANS amotivation scores.
Will correlate with negative symptom severity
 Measures [FP − NNeu] contrast and [NP − NNeu] contrast at Test/ 
transfer phase (GNG)
[FW − FLA] preference at Test/transfer phase (GLA)
Note: FLA, frequent loss-avoider; FP, familiar-positive; FW, frequent winner; GLA, gain vs loss-avoidance; GNG, Go/NoGo; NNeu, 
novel-neutral; NP, novel-positive; PANSS, Positive and Negative Syndrome Scale; POS, positive symptom dimension score; RL, 
reinforcement learning; RT, response time; SANS, Scale of the Assessment of Negative Symptoms.
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current study followed the methods adopted by previous 
reports16,43 (see supplementary materials). For the hypoth-
esized between-group comparisons (eg, win-stay and lose-
shift scores in both tasks, and overall Go-response rates 
in the GNG task), we report t-values, P-values, estimates 
of effect sizes (ES), and Bayes factors which indicate the 
likelihood of accepting the null hypothesis of no group 
difference (see supplementary table S2). In light of our 
small sample size, which limited power to detect interac-
tion effects, we also did post hoc t-tests and calculated 
ES for variables of key theoretical interest, for descriptive 
purposes. Our overall interpretations were constrained by 
the ANOVA results. Correlation analyses were conducted 
to assess the relationships of RL performance with mea-
sures of symptom severity, cognitive functions, and anti-
psychotic dose.56 We did not apply multiple-comparison 
correction to correlations that were hypothesis-driven 
(table 2), but did so in the case of correlations that were 
not hypothesis-driven.
Results
Performance on the GNG Task
We observed no significant between-group difference 
in the “Go-response bias”, as assessed by participants’ 
overall rate of Go-responding (t44.8  =  0.04, P  =  .97, 
D  =  0.01). Concerning rapid RL measures, there were 
no significant between-group differences in either block 
1 win-stay (t62  =  −1.2, P  =  .25, D  =  0.20) or lose-shift 
scores (t62 = −1.3, P = .21, D = 0.35), but tests of group-
differences in win-stay and lose-shift scores across 
the Acquisition phase revealed small-to-medium ES 
(t62 = −1.5, P = .14, D = 0.40 for win-stay rates; t62 = −1.5, 
P = .13, D = 0.40 for lose-shift rates; figure 1A; supple-
mentary table S2). Regarding overall RL, patients exhib-
ited significantly lower accuracy rates than controls 
during Acquisition (figure  1B). This was confirmed by 
a repeated-measures ANOVA, which revealed signifi-
cant main effects of group (F1,62 = 9.7, P = .003; controls 
performing better than patients), block (F1.7,107.3  =  86.3, 
P < .001; performance improving over time), and valence 
(F1,62  =  115.6, P < .001; performance better with posi-
tive than negative stimuli). A significant valence × block 
interaction was also observed (F2,124  =  64.3, P < .001). 
This is the result of accuracy for negative stimuli rapidly 
increasing after block 1, whereas performance for posi-
tive stimuli was largely stable across blocks. None of the 
other interaction effects approached significance (all Fs 
< 1). To better understand the nature of the main effect 
of group, we examined overall performance on the gain 
and loss stimuli. Controls performed much better than 
patients on the gain stimuli (t62 = −2.8, P = .01, D = 0.80), 
Fig. 1. Performance of patients and controls on the Go/NoGo (GNG) task. (A) Win-stay and lose-shift scores from the first block 
and across Acquisition; (B) Performance across the Acquisition phase, expressed in percentages of appropriate responses; (C) Average 
response-time to positive stimuli across Acquisition; (D) Go-response rates to familiar and novel stimuli in the Test/transfer phase, 
controlling for Go-response rates to neutral stimuli.
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and numerically better than patients on the loss stimuli 
(t62 = −1.4, P =  .16, D = 0.38). While these ES appear 
to be of somewhat different magnitudes, this difference 
was not substantial enough to yield a significant group 
× valence interaction. Regarding Go-response latencies 
to positive stimuli, we observed a main effect of group 
(F1,62 = 8.4, P = .005; patients slower than controls) and 
a significant main effect of block (F2,124 = 17.5, P < .001; 
figure  1C), but we found no significant group × block 
interaction (F2,124 = 0.2, P = .86). There was no group-dif-
ference on response-time acceleration to positive stimuli 
(t62 = 0.52, P = .61).
Finally, concerning the postacquisition of value-based 
preferences (as assessed by Go-response rates to Test/
transfer stimuli), a 2-way ANOVA revealed a main effect 
of trial-type (F3,186 = 321.6, P < .001) and a trend toward 
group × trial-type interaction (F3,186 = 2.2, P = .088), but 
no main effect of group (F1,62 = 0.6, P = .44; figure 1D). 
These results thus indicated comparable performance 
between patients and controls on value-guided decision 
making (see supplementary materials for additional 
exploratory analyses).
Performance on the GLA Task
On the GLA tasks, patients showed evidence of impaired 
rapid RL, in that they displayed significantly lower win-
stay rates in both block 1 and across the Acquisition phase 
than controls (both with t62  =  −2.9, P  =  .01, D  =  0.70; 
figure  2A). Group-differences in lose-shift rates were 
Fig. 2. Performance of patients and controls on the gain vs loss-avoidance (GLA) task. (A) Win-stay and lose-shift scores from the first 
block and across Acquisition; (B) Performance across Acquisition blocks: Gain/Miss pairs; (C) Performance across Acquisition blocks: 
Loss/Avoid pairs; (D) Rates of choosing the option with higher EV from novel stimulus-pairings in the Test/transfer phase. * P < .05. 
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small-to-medium (t62 = −0.8, P = .42, D = 0.15 for block 1; 
t62 = −1.8, P = 0.07, D = 0.45 for the Acquisition phase). 
Patients again showed evidence of a deficit in overall RL, 
as a repeated-measures ANOVA revealed significant main 
effects of group (F1,62 = 7.7, P = .007; patients performing 
worse than controls), block (F2.6,158.9 = 66.7, P < .001; per-
formance improving over time), and probability (F1,62 = 5.9, 
P = .02; better performance with 90% than 80% pairs; see 
figure 2, Panels B and C, for overall RL patterns across 
blocks). The main effect of valence was not significant 
(F1,62 = 0.03, P = .86), and there were no significant higher-
order interactions, although group × probability inter-
action trended toward significance (F1,62 = 2.8, P =  .10). 
Patients showed somewhat more substantial impairment 
with the 90% stimuli (t39.6 = −3.5, P = .001, D = 0.89) than 
the 80% stimuli (t62 = −1.1, P = .27, D = 0.29; figure 2), an 
effect we observed in our prior study of chronic patients. 
Again, to better understand the nature of the main effect 
of group, we examined overall performance on the gain 
and loss-avoidance stimuli. There was no evidence of dif-
ferential impairment, as controls performed better than 
patients on both the gain (t = −2.1, P = .04, D = −0.63), 
and the loss-avoidance stimuli (t = −2.6, P = .01, D = 0.70). 
Comparable GLA difference scores during Acquisition 
were observed between patients and controls (t62 = 0.41, 
P = .68). We also failed to find significant group differences 
regarding stimulus preference in the Test/transfer phase 
(figure 2D), including between the gain and loss-avoidance 
stimuli that are critical for evaluating the role of EV in guid-
ing decisions. Thus, despite impaired performance during 
Acquisition, patients were able to use their experience with 
the stimulus items to develop similar preferences, relative 
to controls, when faced with novel stimulus-pairings.
Relationships Between RL Measures and Clinical 
Variables
We observed a significant positive correlation between 
PANSS positive symptom scores and overall Go-response 
rates from the GNG task (supplementary table S4; supple-
mentary figure S1). Significant correlations were observed 
between SANS amotivation scores and Go-response rates 
to Familiar-Positive stimuli in the Test/transfer phase of 
the GNG task, and between SANS total scores and win-
stay rates across the Acquisition phase of the GLA task 
(supplementary table S3; figure 3). There were no signifi-
cant correlations between RL measures and ratings of 
disorganization or depressive symptoms. No significant 
correlations were observed between RL variables and anti-
psychotic dose when corrected for multiple-comparisons 
(supplementary table S4). Furthermore, no significant 
correlations were observed between RL variables and 
measures of IQ, working memory, episodic memory, or 
vigilance in FEP patients after correction for multiple com-
parisons was applied (see supplementary tables S5 and S6).
Discussion
Across both experimental paradigms, there was evidence 
for mild RL impairment in medicated FEP patients as 
seen in significant main effects of group on overall perfor-
mance during the Acquisition phase of both tasks. This 
Acquisition deficit was not limited to positively valenced 
items on either task, however. On both tasks, FEP patients 
exhibited reliable deficits in the loss-avoidance condition 
(ES of group-difference = 0.70 for the GLA; ES of group-
difference = 0.38 for the GNG). Contrary to our hypoth-
esis, FEP patients exhibited comparable performance in 
value-guided decision making in the Test/transfer phase 
of the GNG task, as well as a normative preference for 
gain stimuli, relative to loss-avoidance stimuli, on the 
GLA task. Finally, as hypothesized, we found associations 
between negative symptoms scores and reward-driven 
learning measures from both tasks, and we observed that 
patients’ overall Go rates from the GNG task correlated 
with positive symptom scores (see table 2).
In short, RL impairments in FEP appear to be less 
severe and more circumscribed than those observed in 
chronic SZ tested on the same tasks.16,43 We found some 
evidence that FEP patients exhibited a deficit in using 
positive RPEs to modify value representations, similar to 
chronically ill patients.15,16,23,24 However, given the fact that 
Fig. 3. Scatter plots illustrating relationships between experimental variables and (A) positive symptoms and (B) negative symptoms.
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our FEP patients had much less severe negative symptoms 
(mean overall SANS = 14.2 for patients performing GNG; 
mean overall SANS = 11.2 for patients performing GLA) 
than the MPRC samples (mean overall SANS = 32.8 for 
patients performing GNG16; mean overall SANS = 37.0 
for high-negative-symptom patients performing GLA43; 
mean overall SANS  =  22.9 for low-negative-symptom 
patients performing GLA43), we expected some of the 
deficits most closely associated with severe negative symp-
toms to be absent in the current FEP cohort. This was, 
in fact, that case. Specifically, our finding of marginal 
group-differences in lose-shift rates, with discrepant ESs 
across tasks, contrasts with the robust deficits in lose-shift 
behavior observed in chronic patients in 2 previous stud-
ies.15,16 Results from the current study may suggest that the 
ability to use negative RPEs to rapidly update value repre-
sentations is less impaired in clinically stable FEP patients. 
Additionally, unlike chronic patients with severe negative 
symptoms,43 FEP patients and controls showed similar 
preferences for frequently rewarded stimuli (positive EV) 
over stimuli frequently associated with loss-avoidance 
(negative EV), on the GLA task, suggesting that FEP 
patients were using EV representations to guide decision 
making. The fact that EV representation was intact in a 
FEP sample with low levels of negative symptoms and 
in chronic patients with low levels of negative symptoms, 
may be seen as additional evidence for the specificity of 
the relationship between negative symptom severity and 
the ability to use EV to guide behavior.
Importantly, we still saw modest associations between 
negative symptoms scores and reward-driven learning 
measures despite the reduced dynamic range of negative 
symptoms in the current FEP sample. We also observed 
a significant correlation between positive symptom scores 
and overall Go-response rates from the GNG task, 
thought to reflect tonic striatal dopamine levels. Our find-
ing that the general tendency to execute Go-responses was 
characteristic of FEP patients with the most severe posi-
tive symptoms accords with the notion that Go-response 
rates and psychotic symptoms may be of similar origin.42,57
We interpret our findings of a relatively spared ability 
to use acquired value representations to guide subsequent 
responding, in FEP patients, to be suggestive of both an 
intact or restored (BG-dependent) habit-learning system, 
and preserved capacity to draw on ventromedial prefron-
tal cortex value representations in making choices.6,13 
Rapid/explicit RL, on the other hand, is believed to rely 
most heavily on lateral prefrontal and hippocampal sys-
tems.10–12,58 It is possible that FEP patients rely more heav-
ily on BG function, during the Acquisition, in order to 
learn across trial blocks and achieve similar performance 
levels in the Test/transfer phases of our tasks. That is, 
patients and controls may be using different learning 
strategies during the Acquisition phases.
How do we explain differences in findings across tasks? 
Several factors can be speculatively considered. In the 
GNG task, Pavlovian biases (respond for reward, with-
hold response for punishment-avoidance) may serve to 
support performance, whereas, in the GLA task, par-
ticipants must respond both to gain rewards and avoid 
punishments. In the GNG paradigm, negative feedback 
is provided for choosing a response to single stimulus, 
whereas, in the GLA paradigm, negative feedback for 
the choice of one stimulus (from a stimulus-pair) must be 
used to learn that the other stimulus is likely more opti-
mal—perhaps involving demands on working memory. 
By contrast, it is possible that response-selection (as is 
required for the GNG task) places greater demands of 
BG-driven procedural learning capacities.
In addition to differences in the symptom profiles of the 
patient samples in the respective studies, several other fac-
tors may account for the discrepant findings between the 
current FEP sample and the chronic patients examined at 
the MPRC.16,43 First, the current FEP cohort (mean age: 
24.1 y for the GNG task, 24.8 y for the GLA task) was 
much younger than the MPRC samples (average age: 40 
y),16,43 and there is evidence of an effect of age on RL per-
formance.59 Second, patients in the current study had much 
shorter illness duration than those in our previous stud-
ies.16,43 Thus, it is not possible for us to distinguish between 
an effect of negative symptom severity and an effect of ill-
ness chronicity. Examining the longitudinal course of RL 
impairments in first-episode cohorts would help answer 
this question. Third, our FEP cohort showed evidence 
of relatively preserved learning and memory from several 
standardized measures. While these measures were not 
correlated with RL performance, the fact that this cohort 
of patients failed to demonstrate deficits that are common 
in SZ samples may raise the question of whether this was 
an atypical sample. Finally, roughly half of patients stud-
ied at the MPRC16,43 were treatment-resistant with clozap-
ine being prescribed. In contrast, the current sample had 
been clinically stabilized with treatment and the majority 
(74.2%) achieved positive symptom remission with SGAs 
other than clozapine (according to criteria from Andreasen 
et al.60). The limited variance in psychosis severity ratings 
might explain the absence of Go-response bias in the entire 
sample of FEP patients.
Several study limitations need to be acknowledged. 
Our sample size is modest, and our power to detect 
small effects was limited. Also, because all patients in 
the current study were receiving antipsychotics at the 
time of testing, we cannot rule out an effect of dopa-
mine D2-receptor antagonists on RL.25,26,61–63 Prospective 
investigation of RL prior to and following antipsychotic 
treatment in FEP patients is required to differentiate the 
effects of illness and medication on RL.
Supplementary Material
Supplementary material is available at http://schizophre-
niabulletin.oxfordjournals.org.
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